Funding Opportunity: Increasing Uptake of Long-Acting Injectable Antiretrovirals Among People with HIV (HRSA-22-155)

HRSA HIV/AIDS Bureau (HAB)

This HRSA HIV/AIDS Bureau webinar reviewed the funding opportunity, Increasing Uptake of Long-Acting Injectable Antiretrovirals Among People with HIV (HRSA-22-155). "The purpose of this program is to develop, implement, and evaluate protocols for successful use of long-acting injectable (LAI) antiretroviral (ARV) medication within clinical practice."

Supporting Files

Part of Collection

HRSA HAB Notice of Funding Opportunity (NOFO) Announcements

We'd like your feedback

Was this page helpful?
I found this page helpful because the content on the page:
Check all that apply
I did not find this page helpful because the content on the page:
Check all that apply
Please include an email address if you would like a response
Please include an email address if you would like a response
Did you use this approach in your work?
Not yet because
If no, why not?